In the past year, there were an estimated 53 990 new cases of thyroid cancer in the United States, representing a 3-fold increase in incidence during the past 3 decades.1 While most of this increase has been attributed to sonographic detection of small, localized papillary thyroid cancers, there has been an increase in incidence of all stages of thyroid cancer.2,3 Despite this increase in the number of individuals diagnosed with thyroid cancer, mortality has increased only slightly and has ranged from 0.4 to 0.5 per 100 000 people per year since 1980. Approximately 2060 people were estimated to die from thyroid cancer in the United States in 2018.1
Zanocco KA, Hershman JM, Leung AM. Active Surveillance of Low-Risk Thyroid Cancer. JAMA. 2019;321(20):2020–2021. doi:https://doi.org/10.1001/jama.2019.5350
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: